Skip to main content

Blog Archives

Older posts
Newer posts

Pioneering Novel Drug Delivery Systems: The Dr. Paul Janssen Award Symposium

Since 2004, the Dr. Paul Janssen Award for Biomedical Research has honored scientists who have made a transformational contribution toward the improvement of human health. This prestigious award honors the legacy of Dr. Paul Janssen, an exceptionally gifted and passionate scientist who revolutionized modern medicine and inspired a new generation of researchers.

This half-day virtual symposium will celebrate the 2023 Honoree, Dr. Robert Langer, and his pioneering work. You can learn more about Dr. Langer below. We are proud to offer this event free of cost to anyone interested in celebrating scientific innovation. Registration is required.

Sponsors

Presented by

The logo for The New York Academy of Sciences.

Sponsored by

Artificial Intelligence & Engineered Tissues For Cardiac Disease Therapeutics

Developing targeted therapies for rare cardiomyopathies is challenging: difficulties identifying patients, delivering therapeutics, and accessing heart tissue results in a 50% mortality rate 5 years after diagnosis.  Early, accurate disease detection and classification can significantly improve outcomes for patients with rare cardiomyopathies. Achieving these goals requires multiple novel technologies to coalesce that will enable early patient identification, deepen our understanding of the disease process, improve modeling of human pathophysiology, accelerate testing of drug candidates, and leverage novel therapeutic modalities to target the heart specifically, safely and effectively.

This two-day conference will convene industry scientists, academics, and clinicians to understand the integration of artificial intelligence and engineered tissues for safe and effective delivery of novel therapeutics for patients with arrhythmogenic, hypertrophic, and dilated cardiomyopathies.

2022 Innovators in Science: Gastroenterology

This one-day symposium will bring together researchers, physicians, industry professionals, and patient advocates to exchange new knowledge on novel research approaches, expanding our understanding of disease development, novel paths to treatment, and ways to improve the lives of those living with GI and liver disease.

Frontiers in Cancer Immunotherapy 2022

This three-day meeting will convene immuno-oncology experts across academia and industry to share cutting-edge discoveries and to advance the development of novel cancer immunotherapies.

Eleventh Cooley’s Anemia Symposium

Global experts explore the gene regulation of hemoglobin; the pathophysiology of iron overload, clinical management, emerging therapies, co-morbidities, and updates from clinical trials using gene addition, gene editing, and alternative donor source hematopoietic stem cell transplantation, among other topics central to thalassemia syndromes.

The Future of Vaccinology

A healthcare professional gives a patient a vaccine shot.

This two-day conference will convene leaders in vaccinology, virology, immunology, biotechnology, microbiology, systems biology, and health policy. Session topics include a look back at advances in vaccine development, updates from present-day vaccinology, a discussion on how vaccine development can be strengthened based on COVID-19 vaccine learnings, pharma company pipeline updates, next generation vaccine adjuvants, improving immune measures, and more.

Advances in Pain

Researchers are opening up new avenues in our understanding of pain. This symposium will explore dissection of central pain circuits, genetics, biomarkers, emerging therapies, neuro-immune and auto-immune mechanisms, sex and ethnic differences, and innovations in the identification and development of new therapeutic targets for pain.

Neurodegeneration and Proteostasis

This symposium will bring together experts in proteostasis biology and neurodegenerative disease, along with clinicians, drug developers, and investors to discuss emerging therapies targeting proteostasis pathways to treat neurodegenerative disease.

Calcium in Global Health and Nutrition

Calcium is an essential micronutrient for human health. An estimated 3.5 billion people around the globe are at risk of inadequate dietary intake of calcium. While primarily associated with bone health, calcium has also been shown to reduce the risk of preeclampsia and associated complications, which are leading causes of maternal morbidity and mortality. This webinar is the first in a two-part series on Calcium in Global Health and Nutrition, and will highlight the conclusions of the Calcium Task Force convened by the Nutrition Science Program at The New York Academy of Sciences.

Genome Integrity Discussion Group 2022

Our genomes are composed of the sum total of genetic material necessary to encode the blueprint for human life. The effective maintenance of genome integrity and stability is essential for normal cell division, normal function of our tissues and organs, healthy aging, and the prevention of diseases such as cancer. The processes that regulate genome integrity maintenance include sensing, signaling, and repair of DNA damage, processing of DNA damage in the context of chromatin and chromosomes, cell cycle checkpoint control, and control of cell death. Many of the basic aspects of genome integrity—such as how cells sense and process DNA damage—are still not well understood.

Our portfolio of events and publications in Genome Integrity seek to successfully map the mechanisms by which these regulatory processes act or go awry, presenting an exciting avenue for identifying novel approaches for protecting against disease-causing errors and restoring function.

Older posts
Newer posts